Company: HURA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-313799
Chunk: 12

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-12-10
Form: 424B5
Chunk 12
---
 offered in this offering.

There is no established public trading market for
the Warrants being offered in this offering and we do not expect a market to develop. In addition, we do not intend to apply to list the Warrants on any national securities exchange or other nationally recognized trading system, including Nasdaq.
Without an active market, the liquidity of such Warrants will be limited.

Holders of our Warrants will have no rights as a stockholder until they acquire our Common Stock, except as otherwise provided in the Warrants.

Until you acquire shares of our Common Stock upon exercise
of the Warrants you will have no rights with respect to shares of our Common Stock issuable upon exercise of such Warrants, except as otherwise provided in the Warrants. Upon exercise of your Warrants, you will be entitled to exercise the rights of
a stockholder only as to matters for which the record date occurs after the exercise date.

If you purchase our Common Stock and Warrants in this offering, you will incur immediate and substantial dilution in the book value of your shares.

The offering price in this offering
will be substantially higher than the net tangible book value per share of our Common Stock. Investors purchasing Common Stock in this offering will pay a price per share that substantially exceeds the book value of our tangible assets after
subtracting our liabilities. As a result, investors purchasing Common Stock in this offering will incur immediate dilution of $1.50 per share.

As a result of the dilution to investors purchasing securities in this offering, investors may receive significantly less than the purchase
price paid in this offering, if anything, in the event of our liquidation. For a further description of the dilution that you will incur as a result of purchasing securities in this offering, see “Dilution.”

The Warrants are speculative in nature.

The Warrants offered hereby do not confer any rights of Common Stock ownership on their holders, such as voting rights or the right to receive
dividends, but rather merely represent the right to acquire shares of Common

S-8

Stock at a fixed price. Specifically, commencing six months after the date of issuance, holders of the Warrants may acquire the Common Stock issuable upon exercise of such Warrants at an exercise
price of $1.95 per share. Moreover, following this offering, the market value of the Warrants is uncertain and there can be no assurance that the market value of the Warrants will equal or exceed their offering price. Further, there can be no